Principal Financial Group
EIGR

Principal Financial Group’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History

Principal Financial Group’s Portfolio EIGR Stock Details EIGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-450
Closed -$12.1K – 2526
2023
Q1 		$12.1K Sell
450
-19
-4% -$512 ﹤0.01% 2440
2022
Q4 		$16.6K Buy
+469
New +$16.6K ﹤0.01% 2409